Cargando…

Effects of Vivifrail multicomponent intervention on functional capacity: a multicentre, randomized controlled trial

BACKGROUND: Physical exercise is an effective strategy for preserving functional capacity and improving the symptoms of frailty in older adults. In addition to functional gains, exercise is considered to be a cornerstone for enhancing cognitive function in frail older adults with cognitive impairmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Casas‐Herrero, Álvaro, Sáez de Asteasu, Mikel L., Antón‐Rodrigo, Iván, Sánchez‐Sánchez, Juan Luis, Montero‐Odasso, Manuel, Marín‐Epelde, Itxaso, Ramón‐Espinoza, Fernanda, Zambom‐Ferraresi, Fabricio, Petidier‐Torregrosa, Roberto, Elexpuru‐Estomba, Jaione, Álvarez‐Bustos, Alejandro, Galbete, Arkaitz, Martínez‐Velilla, Nicolás, Izquierdo, Mikel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977963/
https://www.ncbi.nlm.nih.gov/pubmed/35150086
http://dx.doi.org/10.1002/jcsm.12925
_version_ 1784680878623948800
author Casas‐Herrero, Álvaro
Sáez de Asteasu, Mikel L.
Antón‐Rodrigo, Iván
Sánchez‐Sánchez, Juan Luis
Montero‐Odasso, Manuel
Marín‐Epelde, Itxaso
Ramón‐Espinoza, Fernanda
Zambom‐Ferraresi, Fabricio
Petidier‐Torregrosa, Roberto
Elexpuru‐Estomba, Jaione
Álvarez‐Bustos, Alejandro
Galbete, Arkaitz
Martínez‐Velilla, Nicolás
Izquierdo, Mikel
author_facet Casas‐Herrero, Álvaro
Sáez de Asteasu, Mikel L.
Antón‐Rodrigo, Iván
Sánchez‐Sánchez, Juan Luis
Montero‐Odasso, Manuel
Marín‐Epelde, Itxaso
Ramón‐Espinoza, Fernanda
Zambom‐Ferraresi, Fabricio
Petidier‐Torregrosa, Roberto
Elexpuru‐Estomba, Jaione
Álvarez‐Bustos, Alejandro
Galbete, Arkaitz
Martínez‐Velilla, Nicolás
Izquierdo, Mikel
author_sort Casas‐Herrero, Álvaro
collection PubMed
description BACKGROUND: Physical exercise is an effective strategy for preserving functional capacity and improving the symptoms of frailty in older adults. In addition to functional gains, exercise is considered to be a cornerstone for enhancing cognitive function in frail older adults with cognitive impairment and dementia. We assessed the effects of the Vivifrail exercise intervention for functional capacity, cognition, and well‐being status in community‐dwelling older adults. METHODS: In a multicentre randomized controlled trial conducted in three tertiary hospitals in Spain, a total of 188 older patients with mild cognitive impairment or mild dementia (aged >75 years) were randomly assigned to an exercise intervention (n = 88) or a usual‐care, control (n = 100) group. The intervention was based on the Vivifrail tailored multicomponent exercise programme, which included resistance, balance, flexibility (3 days/week), and gait‐retraining exercises (5 days/week) and was performed for three consecutive months (http://vivifrail.com). The usual‐care group received habitual outpatient care. The main endpoint was change in functional capacity from baseline to 1 and 3 months, assessed with the Short Physical Performance Battery (SPPB). Secondary endpoints were changes in cognitive function and handgrip strength after 1 and 3 months, and well‐being status, falls, hospital admission rate, visits to the emergency department, and mortality after 3 months. RESULTS: The Vivifrail exercise programme provided significant benefits in functional capacity over usual‐care. The mean adherence to the exercise sessions was 79% in the first month and 68% in the following 2 months. The intervention group showed a mean increase (over the control group) of 0.86 points on the SPPB scale (95% confidence interval [CI] 0.32, 1.41 points; P < 0.01) after 1 month of intervention and 1.40 points (95% CI 0.82, 1.98 points; P < 0.001) after 3 months. Participants in the usual‐care group showed no significant benefit in functional capacity (mean change of −0.17 points [95% CI −0.54, 0.19 points] after 1 month and −0.33 points [95% CI −0.70, 0.04 points] after 3 months), whereas the exercise intervention reversed this trend (0.69 points [95% CI 0.29, 1.09 points] after 1 month and 1.07 points [95% CI 0.63, 1.51 points] after 3 months). Exercise group also obtained significant benefits in cognitive function, muscle function, and depression after 3 months over control group (P < 0.05). No between‐group differences were obtained in other secondary endpoints (P > 0.05). CONCLUSIONS: The Vivifrail exercise training programme is an effective and safe therapy for improving functional capacity in community‐dwelling frail/prefrail older patients with mild cognitive impairment or mild dementia and also seems to have beneficial effect on cognition, muscle function, and mood status.
format Online
Article
Text
id pubmed-8977963
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-89779632022-04-05 Effects of Vivifrail multicomponent intervention on functional capacity: a multicentre, randomized controlled trial Casas‐Herrero, Álvaro Sáez de Asteasu, Mikel L. Antón‐Rodrigo, Iván Sánchez‐Sánchez, Juan Luis Montero‐Odasso, Manuel Marín‐Epelde, Itxaso Ramón‐Espinoza, Fernanda Zambom‐Ferraresi, Fabricio Petidier‐Torregrosa, Roberto Elexpuru‐Estomba, Jaione Álvarez‐Bustos, Alejandro Galbete, Arkaitz Martínez‐Velilla, Nicolás Izquierdo, Mikel J Cachexia Sarcopenia Muscle Original Articles BACKGROUND: Physical exercise is an effective strategy for preserving functional capacity and improving the symptoms of frailty in older adults. In addition to functional gains, exercise is considered to be a cornerstone for enhancing cognitive function in frail older adults with cognitive impairment and dementia. We assessed the effects of the Vivifrail exercise intervention for functional capacity, cognition, and well‐being status in community‐dwelling older adults. METHODS: In a multicentre randomized controlled trial conducted in three tertiary hospitals in Spain, a total of 188 older patients with mild cognitive impairment or mild dementia (aged >75 years) were randomly assigned to an exercise intervention (n = 88) or a usual‐care, control (n = 100) group. The intervention was based on the Vivifrail tailored multicomponent exercise programme, which included resistance, balance, flexibility (3 days/week), and gait‐retraining exercises (5 days/week) and was performed for three consecutive months (http://vivifrail.com). The usual‐care group received habitual outpatient care. The main endpoint was change in functional capacity from baseline to 1 and 3 months, assessed with the Short Physical Performance Battery (SPPB). Secondary endpoints were changes in cognitive function and handgrip strength after 1 and 3 months, and well‐being status, falls, hospital admission rate, visits to the emergency department, and mortality after 3 months. RESULTS: The Vivifrail exercise programme provided significant benefits in functional capacity over usual‐care. The mean adherence to the exercise sessions was 79% in the first month and 68% in the following 2 months. The intervention group showed a mean increase (over the control group) of 0.86 points on the SPPB scale (95% confidence interval [CI] 0.32, 1.41 points; P < 0.01) after 1 month of intervention and 1.40 points (95% CI 0.82, 1.98 points; P < 0.001) after 3 months. Participants in the usual‐care group showed no significant benefit in functional capacity (mean change of −0.17 points [95% CI −0.54, 0.19 points] after 1 month and −0.33 points [95% CI −0.70, 0.04 points] after 3 months), whereas the exercise intervention reversed this trend (0.69 points [95% CI 0.29, 1.09 points] after 1 month and 1.07 points [95% CI 0.63, 1.51 points] after 3 months). Exercise group also obtained significant benefits in cognitive function, muscle function, and depression after 3 months over control group (P < 0.05). No between‐group differences were obtained in other secondary endpoints (P > 0.05). CONCLUSIONS: The Vivifrail exercise training programme is an effective and safe therapy for improving functional capacity in community‐dwelling frail/prefrail older patients with mild cognitive impairment or mild dementia and also seems to have beneficial effect on cognition, muscle function, and mood status. John Wiley and Sons Inc. 2022-02-11 2022-04 /pmc/articles/PMC8977963/ /pubmed/35150086 http://dx.doi.org/10.1002/jcsm.12925 Text en © 2022 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Casas‐Herrero, Álvaro
Sáez de Asteasu, Mikel L.
Antón‐Rodrigo, Iván
Sánchez‐Sánchez, Juan Luis
Montero‐Odasso, Manuel
Marín‐Epelde, Itxaso
Ramón‐Espinoza, Fernanda
Zambom‐Ferraresi, Fabricio
Petidier‐Torregrosa, Roberto
Elexpuru‐Estomba, Jaione
Álvarez‐Bustos, Alejandro
Galbete, Arkaitz
Martínez‐Velilla, Nicolás
Izquierdo, Mikel
Effects of Vivifrail multicomponent intervention on functional capacity: a multicentre, randomized controlled trial
title Effects of Vivifrail multicomponent intervention on functional capacity: a multicentre, randomized controlled trial
title_full Effects of Vivifrail multicomponent intervention on functional capacity: a multicentre, randomized controlled trial
title_fullStr Effects of Vivifrail multicomponent intervention on functional capacity: a multicentre, randomized controlled trial
title_full_unstemmed Effects of Vivifrail multicomponent intervention on functional capacity: a multicentre, randomized controlled trial
title_short Effects of Vivifrail multicomponent intervention on functional capacity: a multicentre, randomized controlled trial
title_sort effects of vivifrail multicomponent intervention on functional capacity: a multicentre, randomized controlled trial
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977963/
https://www.ncbi.nlm.nih.gov/pubmed/35150086
http://dx.doi.org/10.1002/jcsm.12925
work_keys_str_mv AT casasherreroalvaro effectsofvivifrailmulticomponentinterventiononfunctionalcapacityamulticentrerandomizedcontrolledtrial
AT saezdeasteasumikell effectsofvivifrailmulticomponentinterventiononfunctionalcapacityamulticentrerandomizedcontrolledtrial
AT antonrodrigoivan effectsofvivifrailmulticomponentinterventiononfunctionalcapacityamulticentrerandomizedcontrolledtrial
AT sanchezsanchezjuanluis effectsofvivifrailmulticomponentinterventiononfunctionalcapacityamulticentrerandomizedcontrolledtrial
AT monteroodassomanuel effectsofvivifrailmulticomponentinterventiononfunctionalcapacityamulticentrerandomizedcontrolledtrial
AT marinepeldeitxaso effectsofvivifrailmulticomponentinterventiononfunctionalcapacityamulticentrerandomizedcontrolledtrial
AT ramonespinozafernanda effectsofvivifrailmulticomponentinterventiononfunctionalcapacityamulticentrerandomizedcontrolledtrial
AT zambomferraresifabricio effectsofvivifrailmulticomponentinterventiononfunctionalcapacityamulticentrerandomizedcontrolledtrial
AT petidiertorregrosaroberto effectsofvivifrailmulticomponentinterventiononfunctionalcapacityamulticentrerandomizedcontrolledtrial
AT elexpuruestombajaione effectsofvivifrailmulticomponentinterventiononfunctionalcapacityamulticentrerandomizedcontrolledtrial
AT alvarezbustosalejandro effectsofvivifrailmulticomponentinterventiononfunctionalcapacityamulticentrerandomizedcontrolledtrial
AT galbetearkaitz effectsofvivifrailmulticomponentinterventiononfunctionalcapacityamulticentrerandomizedcontrolledtrial
AT martinezvelillanicolas effectsofvivifrailmulticomponentinterventiononfunctionalcapacityamulticentrerandomizedcontrolledtrial
AT izquierdomikel effectsofvivifrailmulticomponentinterventiononfunctionalcapacityamulticentrerandomizedcontrolledtrial